FDA approved the first biannual injectable PrEP option, Yeztugo (lenacapavir), after studies showed it prevented HIV infection in over 99.9% of participants.
As America’s older adult population grows and geriatricians retire, nurse practitioners are stepping up to provide essential, compassionate care—often in patients’ homes.
A large modeling study evaluated the cost-effectiveness, benefits, and harms of anal cancer screening strategies for men who have sex with men living with HIV.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Results from an international phase III clinical trial show that treatment with sacituzumab govitecan and pembrolizumab helps patients with unresectable, locally advanced or metastatic PD-L1–positive ...
New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.
The FDA has approved Moderna’s mRESVIA vaccine for adults aged 18 to 59 who are at increased risk for RSV, expanding its indication beyond older adults.
A controversial HHS document supporting RFK Jr.'s rollback of COVID vaccine guidance relies on disputed or misrepresented science, prompting outrage from health experts who call it “willful medical disinformation.”